0 666

Cited 0 times in

Effect of β3-adrenoceptor agonist on the micromotion of bilateral major pelvic ganglion-excised rat bladder

Authors
 Hee Seo Son  ;  Soo Young Moon  ;  Joonbeom Kwon  ;  Jang Hwan Kim 
Citation
 NEUROUROLOGY AND URODYNAMICS, Vol.42(2) : 530-538, 2023-02 
Journal Title
NEUROUROLOGY AND URODYNAMICS
ISSN
 0733-2467 
Issue Date
2023-02
MeSH
Adrenergic beta-3 Receptor Agonists / pharmacology ; Animals ; Male ; Rats ; Rats, Sprague-Dawley ; Receptors, Adrenergic ; Receptors, Adrenergic, beta-3 ; Urinary Bladder* ; Urinary Bladder, Overactive*
Keywords
major pelvic ganglion ; micromotions ; models, animal ; neurons, afferent ; overactive bladder ; urinary bladder ; β3-adrenoceptor agonist
Abstract
Aims: Micromotion is an autonomous intramural movement of the bladder, and is believed to be an initial step in the generation of urinary urgency. Therefore, controlling micromotion may be a novel target in overactive bladder (OAB) treatment. However, developing micromotion treatment has been limited by the absence of a standardized animal model. We attempted to create a micromotion animal model and investigated the effectiveness of a β3 -adrenoceptor agonist (CL316,243) on micromotion.

Methods: Bilateral major pelvic ganglia (MPGs) were excised in 18 male Sprague-Dawley rats, resulting in an almost completely denervated bladder. On postoperative Day 7, cystometry was performed. Rats were divided into three treatment groups: CL316,243; β3- adrenoceptor antagonist (SR59230A) pretreated CL316,243; and a nonselective antimuscarinic agent (oxybutynin). Changes in micromotion were evaluated after the intra-arterial administration of each agent.

Results: Low-amplitude oscillations in intravesical pressure (micromotion) were observed 1 week after MPGs excision. Micromotion frequency significantly (p = 0.003) decreased (2.17 ± 3.54 times/5 min) with CL316,243 compared with vehicle (6.33 ± 1.97 times/5 min). Micromotion amplitude also decreased with CL316,243 (1.15 ± 1.93 cmH2 O) compared with vehicle (5.96 ± 5.12 cmH2 O), approaching conventional significance (p = 0.090). No significant decreases in frequency or amplitude were observed with oxybutynin treatment.

Conclusions: Systemic administration of the β3 -adrenoceptor agonist CL316,243 effectively controlled micromotion in bilateral MPGs-excised, almost completely denervated rat bladders. This result indicates that β3 -adrenoceptor agonist may affect the bladder directly, suggesting that it might be effective for overall OAB, regardless of the presence or level of neurological deficits. Bilateral MPGs-excised rats are considered a plausible micromotion animal model suitable for future research.
Full Text
https://onlinelibrary.wiley.com/doi/10.1002/nau.25127
DOI
10.1002/nau.25127
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers
Yonsei Authors
Kim, Jang Hwan(김장환) ORCID logo https://orcid.org/0000-0002-9056-7072
Son, Hee Seo(손희서) ORCID logo https://orcid.org/0000-0001-7198-7816
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/193678
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links